KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Acquisitions (2016 - 2024)

Historic Acquisitions for Charles River Laboratories International (CRL) over the last 14 years, with Q2 2024 value amounting to $5.5 million.

  • Charles River Laboratories International's Acquisitions changed N/A to $5.5 million in Q2 2024 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year decrease of 9634.97%. This contributed to the annual value of $5.5 million for FY2024, which is 9718.72% down from last year.
  • As of Q2 2024, Charles River Laboratories International's Acquisitions stood at $5.5 million.
  • Charles River Laboratories International's 5-year Acquisitions high stood at $906.3 million for Q2 2021, and its period low was -$518000.0 during Q4 2020.
  • Moreover, its 5-year median value for Acquisitions was $94.2 million (2021), whereas its average is $199.6 million.
  • Examining YoY changes over the last 5 years, Charles River Laboratories International's Acquisitions showed a top increase of 3855015.17% in 2020 and a maximum decrease of 105925.93% in 2020.
  • Over the past 5 years, Charles River Laboratories International's Acquisitions (Quarter) stood at -$518000.0 in 2020, then skyrocketed by 293.44% to $1.0 million in 2021, then skyrocketed by 28182.63% to $283.4 million in 2022, then tumbled by 48.97% to $144.6 million in 2023, then crashed by 96.21% to $5.5 million in 2024.
  • Its last three reported values are $5.5 million in Q2 2024, $144.6 million for Q4 2023, and $50.2 million during Q2 2023.